# K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

> **NCT02720666** · PHASE1 · COMPLETED · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 12 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** K-001

## Key facts

- **NCT ID:** NCT02720666
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720666, "K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02720666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*